FY2026 · period end Apr '26 · from the 10-K filed Jun 18, 2026
| Metric | FY26Apr '26 | FY25Apr '25 | FY24Apr '24 | FY23Apr '23 | FY22Apr '22 |
|---|---|---|---|---|---|
| Revenue | $36.36B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-K | 0001628280-26-044354 | Apr 24, 2026 | Jun 18, 2026 | Jun 18, 2026 20:27 UTC | EDGAR |
| 8-K | 0001628280-26-040034 | Jun 3, 2026 | Jun 3, 2026 | Jun 3, 2026 10:47 UTC | EDGAR |
| 8-K | 0001628280-26-035959 | May 18, 2026 | May 18, 2026 | May 18, 2026 20:30 UTC | EDGAR |
| 8-K | 0001628280-26-027272 | Apr 24, 2026 | Apr 27, 2026 | Apr 24, 2026 21:45 UTC | EDGAR |
| 8-K | 0001613103-26-000005 | Mar 24, 2026 | Mar 24, 2026 | Mar 24, 2026 20:42 UTC | EDGAR |
| 10-Q | 0001628280-26-011107 | Jan 23, 2026 | Feb 24, 2026 | Feb 24, 2026 21:18 UTC | EDGAR |
| 8-K | 0001628280-26-008300 | Feb 17, 2026 | Feb 17, 2026 | Feb 17, 2026 11:48 UTC | EDGAR |
| 10-Q | 0001628280-25-053988 | Oct 24, 2025 | Nov 25, 2025 | Nov 25, 2025 21:18 UTC | EDGAR |
Direct links to SEC EDGAR. MDT has additional filings available on the SEC site.
6 numbers Medtronic plc later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·FY 2016
Minor restatementwas$5.3B
Revised up in a 10-K.
Operating Income (Loss)·FY 2017
Minor restatementwas$5.3B
Revised up in a 10-K.
Operating Income (Loss)·Q3 2018
Minor restatementwas$1.4B
Revised up in a 10-Q.
Operating Income (Loss)·Q1 2017
Minor restatementwas$1.4B
Revised down in a 10-Q.
Increase (Decrease) in Accounts Payable and Accrued Liabilities·FY 2016
Major restatementwas-$65M
Revised down in a 10-K.
Deferred Tax Liabilities, Intangible Assets·As of Apr 30, 2021
Major restatementwas$320M
Revised up in a 10-K.
MDT is not the only one.
See every restatement we've found across the market — or get an alert the next time MDT revises a number.
Restatements are detected by comparing every vintage of a fact across all of Medtronic plc's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows MDT's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Medtronic plc — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on MDT yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on MDT and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $32.36B |
| $31.23B |
| $31.69B |
| Gross Profit | $23.64B | $21.91B | $21.15B | $20.51B | $21.54B |
|---|
| Operating Income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B |
|---|
| Net Income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B |
|---|
| EPS (Diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 |
|---|
| Metric | FY26Apr '26 | FY25Apr '25 | FY24Apr '24 | FY23Apr '23 | FY22Apr '22 |
|---|---|---|---|---|---|
| Total Assets | $93.03B | $91.68B | $89.98B | $90.95B | $90.98B |
| Total Liabilities | $42.96B | $43.42B | $39.56B | $39.28B | $38.26B |
| Stockholders' Equity | $50.07B | $48.26B | $50.42B | $51.66B | $52.72B |
| Cash & Equivalents | $1.95B | $2.22B | $1.28B | $1.54B | $3.71B |
| Total Debt | $28.13B | $25.64B | $23.93B | $24.34B | $20.37B |
| Metric | FY26Apr '26 | FY25Apr '25 | FY24Apr '24 | FY23Apr '23 | FY22Apr '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7.33B | $7.04B | $6.79B | $6.04B | $7.35B |
| Capital Expenditures | $1.90B | $1.86B | $1.59B | $1.46B | $1.37B |
| Free Cash Flow | $5.43B | $5.18B | $5.20B | $4.58B | $5.98B |
| Metric | FY26Apr '26 | FY25Apr '25 | FY24Apr '24 | FY23Apr '23 | FY22Apr '22 |
|---|---|---|---|---|---|
| Gross Margin | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% |
| Operating Margin | 17.8% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 13.2% | 0.1% | 0.1% | 0.1% | 0.2% |
| Return on Equity | 9.6% | 9.4% | 7.2% | 7.2% | 9.7% |
| Return on Assets | 5.2% | 5.1% | 4.1% | 4.1% | 5.5% |
| Debt / Equity | 0.56× | 0.58× | 0.47× | 0.47× | 0.39× |
